Science and Enterprise

Category: Joint ventures/collaborations

  • Researchers to Study Blood Transfusion Risk in the U.K.

    Researchers in the U.K. will examine the risks and benefits of receiving blood or blood products, including the need for patients to give informed consent before receiving blood. The study will be a collaboration between Helen Busby at the University of Leicester, Julie Kent at University of the West of England in Bristol, and Anne-Maree…

  • New Analytical Tools Reveal Cancer DNA Properties

    Researchers from the St. Jude Children’s Research Hospital – Washington University Pediatric Cancer Genome Project developed a computerized algorithm to better identify genomic properties of cancer cells. Their findings appear in the advance online issue of the journal Nature Methods (paid subscription required). The analytical methods are contained in a software package called Clipping Reveals…

  • International Consortium Sequences Wheat Pathogen Genome

    A group of agricultural scientists has sequenced the genome of a pathogen that causes the wheat disease septoria tritici blotch, responsible for severe crop losses. Their findings appeared 9 June 2011 in the journal PLoS Genetics. The consortium, led by USDA plant pathologist Steven Goodwin included researchers from the U.S., Australia, Brazil, France, Germany, Iran,…

  • New Process Integrates Cancer Lab Studies, Clinical Trials

    A joint project of National Cancer Institute (NCI), Jackson Laboratory in Bar Harbor, Maine, and University of California at Davis plans to develop a more consistent model for integrating the results of preclinical cancer research with human clinical trials. The new process comes under NCI’s Advanced Technology Partnerships Initiative and its Center for Advanced Preclinical…

  • Company, University Partner on Steel Manufacturing Process

    A materials science lab at Ohio State University in Columbus is working with a manufacturer in Detroit to better understand the science behind the small company’s high-performance steel product. The researchers and the company’s president reported their findings last month in the journal Materials Science and Technology (paid subscription required). Gary Cola, founder of the…

  • University Lighting Research Center Gains Industry Backers

    The Smart Lighting Engineering Research Center (ERC) at Rensselaer Polytechnic Institute in Troy, New York has drawn 21 industrial partners to help guide the center’s research programs and move its findings from the lab bench to the marketplace. ERC began in 2008 with funding from National Science Foundation, and is led by Rensselaer. The center’s…

  • Pfizer Adds Mass. Institutions to Translational Network

    Pfizer Inc. in New York is adding eight Massachusetts research institutions to its network of translational research partnerships, called the Centers for Therapeutic Innovation. The company also says it will put the academic network’s headquarters in Boston, a $100 million investment over five years. Jose Carlos Gutierrez-Ramos, Pfizer’s vice-president for  biotherapeutics research and development, says…

  • Mayo Clinic, GE to Research Brain-Scan MRI Technology

    The Mayo Clinic in Rochester, Minnesota and GE Global Research in Niskayuna, New York will conduct research leading to development of a dedicated MRI brain scanner for neurological and psychiatric disorders. Their work is funded by a $5.7 million grant from National Institutes of Health. An MRI brain scanner would be dedicated to diagnose disorders…

  • Prototype U.K. Medical Records Card/Stick Developed

    Two universities in the U.K. have developed a prototype smart card fitted with mass memory stick containing an individual’s medical records. The MyCare Card prototype was developed by City University London and Coventry University, with funding from the Engineering and Physical Sciences Research Council (EPSRC). The MyCare Card, pictured left,  stores personal medical data, such…

  • Collaboration to Develop Second-Generation Malaria Vaccine

    The PATH Malaria Vaccine Initiative (MVI) says it has an agreement with Dutch biopharmaceutical company Crucell N.V., a division of Johnson & Johnson, and GlaxoSmithKline (GSK) to develop a second-generation vaccine against malaria. PATH is an international non-profit organization that helps communities worldwide break longstanding cycles of poor health. According to World Health Organization (WHO),…